What is Labviva worth?
$125.0Mlast known valuation
Labviva last raised $8.0M in its Early Stage VC (Jun 2021).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Labviva
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2021 | Early Stage VC | $8.0M | ▮ | ▮ |
| Apr 2019 | Seed Round | $750K | ▮ | ▮ |
How Labviva's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Labviva, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Labviva worth?
- Labviva's last known valuation is $125.0M.
- How much has Labviva raised?
- Labviva has raised $55.1M in total funding across 2 recorded rounds.
- When did Labviva last raise?
- Labviva last raised in Jun 2021 (Early Stage VC), raising $8.0M.